Back

HCM: who should get an implantable cardioverter defibrillator in Europe and the US in 2022?

4 April 2022 (16:07 - 16:19)
Organised by:
Congress Presentation Part of: Risk calculators in arrhythmias: are they useful? Genetic Aspects of Arrhythmias EHRA Premium Access EHRA 2022

About the speaker

Photo
Professor Perry Mark Elliott

University College London, London (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail
Genetic risk calculators.
Doctor R. Tadros (Montreal, CA)
Slides Video
Presentation thumbnail
LQTS: how to use the novel calculator.
Doctor H. Tan (Amsterdam, NL)
Slides Video
Presentation thumbnail
ARVC in 2021: do we implant the right patients?
Professor P. Lambiase (London, GB)
Slides Video
Presentation thumbnail
Risk calculators in arrhythmias: are they useful? - discussion.
Video

Access the full session

Session thumbnail
Risk calculators in arrhythmias: are they useful?
Video

The Event

Event poster

EHRA 2022

4 April 2022 16:07 CET
You may be interested in
thumbnail
Congress Presentation
Risk stratification of sudden cardiac death in hypertrophic cardiomyopathy
thumbnail
Congress Presentation
Effectiveness of contemporary risk stratification in patients with hypertrophic cardiomyopathy: a pilot study
thumbnail
Congress Presentation
The challenge of risk stratification in hypertrophic cardiomyopathy: clinical, genetic and imaging insights from a quaternary referral centre

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources